Usefulness of EGFR mutation screening in pleural fluid to predict the clinical outcome of gefitinib treated patients with lung cancer
暂无分享,去创建一个
J. Soh | S. Toyooka | K. Kiura | M. Aoe | H. Date | N. Shimizu | Y. Sano | A. Hiraki | Hiroaki Asano | K. Aoe | K. Sugi | H. Katayama | S. Ichihara